A Therapeutic Area User Guide (TAUG) in the CDISC context supplements general data standards with disease-specific concepts. It contains metadata, examples, and implementation guidelines on how information for a specific indication can be structured using CDASH, SDTM, ADaM, and controlled terminology. The guide thus makes medically specific data collections usable for a standardized data chain.
This clarifies how clinical specifics can be integrated into a general data vocabulary.
From Disease to Data Concept
Many diseases require examinations, scales, event definitions, or progression descriptions that are not self-explanatory in a general data model. A TAUG maps such specialized concepts to a structured representation. For a neurological disease, for example, these might be special functional measurements; in oncology, tumor-related observations; or in infectious diseases, disease-specific laboratory and progression criteria.
CDISC guides extend the Foundational Standards for specific indications within disease areas. Guides have been published for various areas, including Alzheimer’s, diabetes, HIV, multiple sclerosis, vaccines, and various oncological diseases. The standards covered by an individual TAUG vary depending on the topic: some include terminology and SDTM, while others also incorporate CDASH and ADaM.
Content and Project Use
A guide can explain the use of domains and variables, show annotated Case Report Forms, and present example SDTM datasets with their context. Notes on ADaM illustrate how indication-specific concepts can be carried through to analysis. Thus, a TAUG serves as a technical translation aid between the clinical team, CRF design, data management, and programming.
A TAUG does not require every study to be conducted with the same assessments. CDISC emphasizes that the standards describe the data structure but do not dictate which data should be collected, how a clinical trial should proceed, or which endpoints to choose. A study protocol must therefore still justify the medical purpose of the data collection; the guide then assists in the consistent mapping of the chosen information.
The examples in a TAUG are not a complete catalog of all permissible models. They explain typical concepts and show which domains, variables, and terminology may be suitable for a specific indication. A study may deviate if its protocol uses other assessments; in such cases, the additional data elements must be modeled according to the rules of the foundational standards.
When applying a TAUG, compatibility with the standard versions used must also be considered. CDISC publishes supplementary Therapeutic Area Specifications for guides, which can implement examples for different SDTM and SDTMIG versions. Therefore, the project should not merely adopt the visible dataset name from an example but should examine its technical context, the specified terminology, and the foundational standards involved.
Distinction from Therapeutic Area and Foundational Standards
A therapeutic area is a medical classification of diseases or treatment fields. A Therapeutic Area User Guide, however, is a document type with data modeling examples. It does not describe the therapeutic area itself and does not replace clinical expertise for the respective disease.
Furthermore, a TAUG does not replace a CDISC foundational standard. CDASH remains authoritative for data collection, SDTM for tabulation, and ADaM for analysis datasets. The guide only shows how these building blocks are to be applied to specific disease-related content. If a suitable TAUG is missing, teams can still use the foundational standards but must justify and document their modeling decisions with particular care.
This is particularly valuable for global programs when the same disease is investigated with different local documentation habits, and the central data structure needs to remain consistent.
Relevance for clinical trials
For indication-specific endpoints, an early consultation of a TAUG prevents clinical concepts from being forced into unsuitable general variables just before submission. This applies to the selection of CRF fields as well as terminology, vendor data, SDTM mapping, and analysis derivations. Project teams should check which versions of the underlying foundational standards the respective guide addresses and whether their own study is actually covered by its examples.
Full-service CROs like Mediconomics support the application of a TAUG through indication-related CRF reviews, alignment of assessment data with CDASH and SDTM, specifications for external instruments, and data management and biostatistics for the associated analyses. Operational work also includes clarifying data origin and coding when the guide presents multiple permissible representations for a concept.
Frequently Asked Questions (FAQ)
Does a TAUG prescribe the study protocol for an indication?
No. It does not define clinical decisions regarding inclusion criteria, examinations, or endpoints, but rather explains the data structure of selected concepts.
Is there a TAUG for every disease?
No. CDISC publishes guides for various areas, but not for every indication. The absence of a guide does not negate the application of the foundational standards.
Can a TAUG be used without SDTM?
Its benefit lies precisely in its connection to Foundational Standards. Which of these a guide covers is specified on the published CDISC pages for the respective area.
Regulatory References
- CDISC Therapeutic Area User Guides – extend Foundational Standards with indication-specific metadata and examples.
- CDISC CDASH – forms the layer for standardized clinical data collection.
- CDISC SDTM – provides the structure for the tabulation of collected study data.
- CDISC ADaM – describes the datasets for subsequent statistical analysis.
